U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06915974) titled 'Comparison Between Interleukin 6 and Procalcitonin in Detecting Sepsis and Incidence of Mortality in Burn ICU Patients' on Feb. 14.
Brief Summary: The investigators will compare the efficacy of Interleukin-6 (IL-6) as a better indicator than procalcitonin in burn patients with sepsis or septic shock regarding success of treatment and early ICU discharge.
Study Start Date: Jan. 10
Study Type: INTERVENTIONAL
Condition:
Burns
Sepsis
Septic Shock
Death
Intervention:
DIAGNOSTIC_TEST: Interleukin 6
Interleukin 6 and procalcitonin will be sampled for all patients on days 1, 3, 7, and 10
Recruitment Status: RECRUITING
Sponsor: Ain ...